ALLISON SHUKE: Open Payments
NPI 1790415487 · NEW PARIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,535 in 87 payments from 25 companies in 2025. Trend: 2023 $1,916 · 2024 $1,733 · 2025 $1,535
Food & beverage: $1,535
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $292 |
| PFIZER INC. | 11 | $156 |
| AstraZeneca Pharmaceuticals LP | 5 | $147 |
| Ardelyx, Inc. | 6 | $129 |
| Viatris Specialty LLC | 6 | $112 |
| Novo Nordisk Inc | 5 | $84 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Lilly USA, LLC | 4 | $70 |
| Exact Sciences Corporation | 4 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
Products named: IBSRELA, FARXIGA, YUPELRI, VRAYLAR, ELIQUIS, QULIPTA, TRELEGY ELLIPTA, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
